• image
  • image
  • image
 

AIDS Vaccine 2010

at the Omni Hotel at CNN Center

Plenary Speakers

Wednesday, 29 September 2010

08:00 - 09:30
Plenary Session 01: Improving Immunogens and Delivery


08:00 - 08:30

Clues from the Isolation and Structural Analysis of Broadly Neutralizing Anti-HIV-1 Antibodies


John Mascola (view bio)
Vaccine Research Center, NIAID, NIH, USA



Image of Bette Korber 08:30 - 09:00

Designing vaccine inserts with enhanced potential to contend with HIV diversity


Bette Korber (view bio)
Theoretical Biology, Los Alamos National Laboratory, USA




Image of Giuseppe Pantaleo 09:00 - 09:30

Virus Vectors in the Iterative Process of HIV Vaccine Development: What Is Next?


Giuseppe Pantaleo (view bio)
Centre Hospitalier Universitaire Vaudois, Switzerland






Thursday, 30 September, 2010

08:30 - 10:00
Plenary Session 02: Lessons from Host-Virus Interactions


08:30 - 09:00

Innate-Mucosal Immune Interactions During Acute Infection


Ashley Haase (view bio)
Department of Microbiology, University of Minnesota Medical School, USA





09:00 - 09:30

Lessons from Early HIV Infection


Andrew McMichael (view bio)
University of Oxford, United Kingdom






09:30 - 10:00

HIV Transmission and the Role of Antibodies: Lessons from the Settings of Mother-Infant Infection and Superinfection


Julie Overbaugh (view bio)
Fred Hutchinson Cancer Research Center, USA




Friday, 1 October, 2010

10:40 - 13:10
Plenary Session 03: Challenges Facing AIDS Vaccine Development


10:40 - 11:10

Correlates of Immunity: RV144 - Lessons Learned


Nelson Michael (view bio)
US Military HIV Research Program (MHRP) / Walter Reed Army Institute of Research, USA



11:10 - 11:40

Systems biology approaches to HIV vaccine development


Rafick-Pierre Sekaly (view bio)
VGTI Florida, Port St. Lucie, USA and the Université de Montréal, Canada




11:40 - 12:10

The Need for More Efficient Efficacy Trials of HIV Vaccines


Lawrence Corey (view bio)
Fred Hutchinson Cancer Research Center, USA




12:10 - 12:40

Using Partnerships in the Developing World to Accelerate AIDS Vaccine Development


Seth Berkley (view bio)
International AIDS Vaccine Initiative (IAVI), USA



12:40 - 13:10

Impact of Biomedical Prevention Approaches on the Implementation of HIV Vaccine Efficacy Trials


Salim Abdool Karim (view bio)
CAPRISA, University of KwaZulu-Natal, South Africa